WDR5 Antibodies

Santa Cruz Biotechnology delivers a wide array of WDR5 monoclonal antibodies for research in understanding WDR5 protein functions. WDR5 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). WDR5, or WD repeat domain 5, is a critical component of the MLL (Mixed-Lineage Leukemia) complex, which plays a significant role in gene expression regulation and chromatin remodeling. WDR5 maintains proper cellular functions and has been implicated in various biological processes, including development and differentiation. Research has shown that WDR5 expression levels can influence cell proliferation and survival pathways. Dysregulation of WDR5 has been associated with several cancers, making it a vital target for therapeutic research. Understanding WDR5's role in normal development and disease progression continues to be an active area of investigation. Recent studies have highlighted WDR5's involvement in stem cell maintenance and cellular differentiation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of WDR5's role in health and disease.